"Why continue to partner with SMI?" They'll probably kick SMI to the curb at some point, but partnering with SMI accomplished a great thing: they conducted and completed a large successful clinical trial in China without paying for it. Remember that? Read this to refresh your memory -- this would not have happened if they hadn't partnered with SMI:
Now somebody has to submit the application to the NMPA. That's going to take awhile for the NMPA to approve the device so there's lots of time for your bashing while THAT plays out. Lucky you.
"....they added a new director to the board, What exact value-add does he do?" LOL I remember when your FUD assertion was that they would never start the US clinical trial and that there was no proof that the company's Directors were real people. Remember that? Read it again to refresh your memory:
Now you're complaining because there are too MANY Directors? Which Director are you complaining about? Grujic? He was added in March 2023. Here's his bio from the 10-Q. He's a Financing guy. You think the company was harmed by adding a Financing guy to the BOD?
And speaking of 10-Q's... you say "right before 10-K or 10-Q publishing there’s a heavy trading (mostly selling) occurring." Really? "Heavy trading?" You mean the 134,400 traded on March 28th (day of 10-K)? That's about $14,000 and that is a high-volume day for this stock. You think $14,000 is "heavy trading?"
Or the 64,000 shares traded on Nov. 13th, the day the last 10-Q was released? That was about $8,000.
Your assertions of "heavy trading" and "heavy selling" are absurd. There's no heavy selling and no heavy buying. Here's the factual historical data: https://finance.yahoo.com/quote/GTHP/history